Brighton Capital to Acquire Minority Stake in Indegene

Paul, Weiss advised Brighton Park Capital in its $200 million acquisition, alongside The Carlyle Group, of a minority stake in Indegene, a Bangalore-headquartered enterprise healthtech solutions provider. The transaction is subject to customary regulatory approvals and other closing conditions.

The Paul, Weiss team includes, among others, corporate partners Matthew Abbott, Lindsey Wiersma and Marco Masotti and counsel Suhan Shim; tax partner Lindsay Parks; intellectual property partner Charles Googe; litigation partner Jaren Janghorbani; executive compensation partner Lawrence Witdorchic and counsel Jacob Glazeski; real estate partner Peter Fisch; and antitrust counsel Yuni Sobel.